[ad_1]
Melius Research is still upbeat about Dell’s earnings potential, though analyst acknowledges the company needs to soothe investors’ margin fears.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...